GlassScriptPhysician profile
Alan S Kwiatek
NPI 1750387452
$5,170.67
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,604 · 2020: $183 · 2021: $452 · 2022: $420 · 2023: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,915.53 | 2019 | |
| Alcon Vision LLC | $1,569.57 | 2019-2023 | Total30 |
| Johnson & Johnson Vision Care, INC. | $311.53 | 2019-2023 | Acuvue |
| Allergan, INC. | $246.69 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $240.10 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $166.51 | 2022-2023 | Miebo, Infuse, Biotrue One Day |
| Biotissue Holdings INC. | $144.07 | 2023 | |
| Oyster Point Pharma, INC. | $121.81 | 2023 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $120.67 | 2019 | |
| Novartis Pharmaceuticals Corporation | $119.05 | 2021 | |
| Sun Pharmaceutical Industries INC. | $100.69 | 2022 | |
| Menicon America INC | $41.41 | 2021 | |
| Abbvie INC. | $22.60 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $13.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Kwiatek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.